Pillar® ONCO/Reveal™ BRCA1 & BRCA2 Somatic Panel

The ONCO/Reveal BRCA1 & BRCA2 Somatic Panel is specifically designed with shorter amplicons to detect mutations in FFPE samples. The assay sequences the entire coding region of the BRCA1 and BRCA2 genes plus 10bp of flanking introns. Pillar also offers a panel optimized for germline BRCA1 & BRCA2 mutation detection. Both panels use proprietary Stem-Loop Inhibition-Mediated amplification (SLIMamp®) technology for efficient single-tube target enrichment.

Panel highlights

Full BRCA1 and BRCA2 CDS plus flanking sequences 

From sample to library in as little as 5 hours (2hrs hands on) 

Designed to detect mutations in FFPE samples 

>99% coverage uniformity at 0.2x mean coverage

For research use only. Not for use in diagnostic procedures.

Panel specifications

Enrichment chemistry Multiplex PCR using tiled amplicons
Number of pools 1 pool
Number of genes/amplicons 2/196
Number of targets Full coding gene sequence (CDS) with flanking intronic regions (10bp)
Variant types SNVs, indels
Average amplicon size 112bp
Input DNA range 10ng to 60ng (20ng recommended)
Sample types FFPE
Mapping rate 98.4% ± 1.0%
% on-target aligned reads 99.9% ± 0.0%
Coverage uniformity (% targets with >0.2X mean coverage) 99.6% ± 0.5%
Total assay time (from DNA to sequencer) <8 hours
Sequencing platforms Illumina®, MGISEQ™ and Ion Torrent™

Pillar technology

Pillar provides a seamlessly integrated NGS workflow, from panel design to data analysis.


icon of ampPD primer as located on DNA

Primer design platform for reliable amplicon specificity


test tube icon

Enrichment chemistry that enables single-tube amplification


PiVat icon

Bioinformatic tools that deliver sensitive, robust variant calls

Contact an expert

Contact us for technical information or to get a quote

WP Feedback

Dive straight into the feedback!
Login below and you can start commenting using your own user instantly

Scroll to Top